Does Methotrexate Make You Tired and What to Do About It

Methotrexate is one of the most effective medications for rheumatoid arthritis, psoriasis, and several other inflammatory conditions, but fatigue is its single most commonly reported side effect. Surveys of people taking the drug find that roughly half experience tiredness they attribute to methotrexate, making it even more frequent than nausea. The good news is that the fatigue is manageable for most people once you understand what drives it and which strategies actually help.

How Common Is the Fatigue, Really

The numbers vary a bit depending on how researchers ask the question, but they consistently put fatigue at or near the top of the side-effect list. A large registry study of people with inflammatory arthritis found that 46 percent of current methotrexate users reported fatigue as a drug-related side effect, making it the most frequently cited complaint.¹ A separate multicenter survey of patients on stable methotrexate doses put the figure even higher, at 53 percent, with fatigue scoring higher on severity scales than nausea, mouth ulcers, or hair thinning.²

Fatigue does not travel alone, either. About a third of current methotrexate users also report brain fog, that hard-to-describe feeling of mental sluggishness or difficulty concentrating.¹ The two often arrive together in the day or two after a weekly dose and fade as the week goes on, a pattern patients sometimes call “methotrexate hangover.”

Why Methotrexate Causes Tiredness

Methotrexate works by interfering with folate metabolism. That is how it tamps down the overactive immune response that drives rheumatoid arthritis or psoriasis. But folate is not just used by immune cells. It plays a role in energy production, red blood cell formation, and neurotransmitter synthesis throughout the body. When methotrexate blocks the enzymes that process folate, those other systems feel the pinch too.

Research in animal models shows that methotrexate significantly lowers levels of 5-methyltetrahydrofolate, the active form of folate, in both the blood and the fluid surrounding the brain and spinal cord.³ Studies in patients receiving methotrexate have confirmed that this folate depletion also reduces S-adenosylmethionine, a molecule the body depends on for dozens of chemical reactions including those involved in mood regulation and energy.⁴ In short, the same mechanism that makes methotrexate therapeutic also creates a metabolic environment where feeling drained is a predictable side effect.

There is also evidence that methotrexate can directly affect brain cells. Mouse studies have shown that the drug triggers cell death in astrocytes, the support cells of the central nervous system, through that same disruption of folate processing.⁵ While the doses used in cancer treatment are much higher than those for arthritis, the underlying pathway is the same, and this likely explains at least part of the cognitive cloudiness and weariness that lower-dose users describe.

Telling Drug Fatigue Apart from Disease Fatigue

Here is the complication that trips up a lot of people: the diseases methotrexate treats are themselves exhausting. Rheumatoid arthritis, psoriatic arthritis, and psoriasis all drive fatigue through systemic inflammation. In one study, severe fatigue affected 28 percent of people with psoriatic arthritis and 17 percent of those with psoriasis alone, compared to fewer than 2 percent of healthy controls.⁶ Research in early rheumatoid arthritis has found that aggressive treatment of inflammation improves fatigue in some patients but not others, suggesting two overlapping pools of tiredness: one caused by the disease, one caused by something else entirely.⁷

This matters for practical decision-making. If your fatigue consistently spikes in the first 24 to 48 hours after your weekly dose and then eases off, that pattern points toward methotrexate as the culprit. If the tiredness is constant regardless of when you took your dose, the underlying disease or another factor like poor sleep or depression is more likely to blame. Keeping a simple journal that notes your dose day and your energy level each day can help your rheumatologist figure out which scenario fits you.

Folic Acid Supplementation

The single most evidence-backed intervention for methotrexate side effects is folic acid supplementation. A Cochrane review of six trials found that taking either folic acid or folinic acid while on methotrexate reduced gastrointestinal side effects like nausea by about a quarter and cut the risk of abnormal liver enzyme elevations by roughly three-quarters.⁸ People who took folate were also far less likely to stop methotrexate for any reason, with a roughly 60 percent reduction in discontinuation rates.⁸

There is an important distinction between folic acid and folinic acid. Daily folic acid does not appear to reduce methotrexate’s effectiveness against the disease, so most rheumatologists prescribe it routinely. Folinic acid, on the other hand, can interfere with methotrexate’s therapeutic action if taken too close to the dose, and is generally reserved for situations involving actual methotrexate toxicity rather than everyday supplementation.⁹ If you are on methotrexate and not already taking folic acid, that conversation with your doctor should happen sooner rather than later. Most patients are prescribed 1 mg daily or 5 mg once a week on a non-methotrexate day, though the exact regimen varies.

One honest caveat: the Cochrane data on folate supplementation is strongest for nausea and liver protection. Its impact on fatigue specifically is less well quantified by formal trials. Still, because folate depletion is the root mechanism behind much of methotrexate’s side-effect profile, replenishing it logically addresses fatigue too, and the clinical experience of most rheumatologists supports that.

Adjusting How You Take Methotrexate

If folic acid alone does not solve the problem, the next practical step is changing how you take the drug. Several approaches have evidence behind them.

Switching from oral to subcutaneous (injectable) methotrexate consistently shows up as helpful in the research. When methotrexate is injected under the skin, it bypasses the gut entirely, which improves absorption and reduces the gastrointestinal irritation that contributes to the general feeling of being wiped out. A prospective Japanese study found that patients who switched from oral to subcutaneous methotrexate had a significantly greater reduction in nausea and a numerically greater reduction in fatigue compared to those who stayed on oral pills.¹⁰ A broader review of the literature confirms that subcutaneous methotrexate has a generally better tolerability profile than oral methotrexate, particularly for stomach-related effects.¹¹

A survey comparing self-reported side effects across different methotrexate routes tells a more nuanced story, though. In that study, 73 percent of subcutaneous methotrexate users reported fatigue, compared to 56 percent of oral users.¹² That seemingly contradictory finding likely reflects selection bias: patients who get switched to injections are often those who were already having the worst side effects on pills. The comparison of fatigue rates between the groups does not mean injections cause more fatigue. It means the patients who end up on injections tend to be the ones who were struggling more in the first place.

Another approach is splitting the weekly oral dose into two or three smaller doses taken over the same day. A study that tested this strategy found improvements across several side effects, including stomach irritation and nausea, at six months after the switch.¹³ The logic is simple: instead of hitting your body with the full dose at once, spreading it out gives your system time to process each portion more gently.

Exercise, Behavioral Strategies, and Sleep

It sounds counterintuitive to tell a tired person to exercise, but this is one of the best-supported strategies for managing fatigue in inflammatory arthritis. A review of fatigue management in rheumatoid arthritis found that exercise programs, supervised self-management approaches, and cognitive-behavioral therapy all improve fatigue beyond what disease-controlling medication alone achieves.¹⁴ Notably, even when the underlying disease activity was well treated, fatigue often persisted in a subset of patients. That tells us that the fatigue has components beyond inflammation, including deconditioning, disrupted sleep, and psychological factors, all of which respond to behavioral interventions.

Practically, what seems to help most is regular, moderate aerobic activity. Walking, swimming, or cycling at a comfortable pace for 20 to 30 minutes several times a week builds the kind of cardiovascular fitness that counteracts the “always tired” feeling. The trick is starting small. People with inflammatory arthritis who launch into ambitious exercise programs often flare up and quit. A gradual ramp-up, even starting at 10 minutes per session, is more sustainable.

Sleep quality deserves attention too. Methotrexate-related nausea sometimes disrupts sleep on dose night, and chronic pain from the underlying disease can fragment sleep throughout the week. Basic sleep hygiene steps, like keeping a consistent bedtime, limiting screens before bed, and keeping the bedroom cool, are underrated for their cumulative effect on daytime energy. If pain is specifically waking you up at night, that is worth raising with your rheumatologist separately, because treating nighttime pain directly can cascade into better energy during the day.

Timing Your Dose for Minimum Disruption

Many patients discover through trial and error that taking methotrexate in the evening, just before bed, lets them sleep through the worst of the post-dose malaise. By the time they wake up the next morning, the peak of the nausea and fatigue has often passed or at least diminished. This is not studied in rigorous trials, but it is among the most commonly shared practical tips in patient communities and is endorsed by many rheumatologists as a first-line self-management step.

Similarly, if you know that the day after your dose is your worst day, building your schedule around that knowledge helps. Avoiding demanding physical or mental tasks on your “methotrexate day” and stacking them later in the week can make the fatigue feel less disabling even if its absolute severity does not change. The tiredness is easier to tolerate when it is not also wrecking your productivity at work or your plans with family.

Caffeine and Methotrexate

Caffeine has a complicated relationship with methotrexate. Part of how methotrexate reduces inflammation is by increasing local levels of adenosine, a molecule that dampens immune activity. Caffeine blocks adenosine receptors, which has led to concern that heavy coffee drinking could reduce methotrexate’s effectiveness. A randomized controlled trial explored whether caffeine could reduce methotrexate intolerance symptoms by exploiting exactly that receptor-blocking action.¹⁵

The practical takeaway is that moderate caffeine intake, a cup or two of coffee, is unlikely to meaningfully undermine methotrexate therapy for most people, and many patients find it helpful for getting through the post-dose fog. But if you are drinking several cups specifically to power through exhaustion every week, that is a sign to revisit the issue with your doctor rather than caffeinating your way past it. And if your disease seems poorly controlled despite adequate dosing, your rheumatologist might ask about your caffeine habits as part of the troubleshooting.

Alcohol and Liver Considerations

Alcohol comes up in every methotrexate conversation because both the drug and alcohol are processed by the liver. A large study of rheumatoid arthritis patients on methotrexate found that drinking more than 21 units of alcohol per week nearly doubled the risk of liver enzyme elevations, while moderate drinking of up to about 14 units per week did not show a statistically significant increase in liver problems.¹⁶

This matters for fatigue because liver stress can quietly amplify tiredness. If your liver is working harder than it needs to because of alcohol on top of methotrexate, you may feel more fatigued without any single lab result waving a red flag. Most rheumatology guidelines now say that light to moderate drinking is acceptable for methotrexate users, but heavy drinking is a genuine risk factor for both liver damage and worsening side effects. If you are already struggling with methotrexate fatigue, cutting back on alcohol is a reasonable experiment that costs you nothing.

Genetic Variation in Side-Effect Susceptibility

Not everyone on the same dose of methotrexate experiences the same side effects, and genetics is one reason why. Researchers have studied variations in genes that code for the enzymes and transporters involved in folate metabolism, looking for patterns that predict who will have more trouble. A systematic review and meta-analysis found that a specific variation in the RFC-1 gene, which helps transport folate into cells, was associated with increased methotrexate toxicity in European patients with rheumatoid arthritis.¹⁷ Other commonly studied gene variants, including MTHFR, did not show a consistent link to toxicity across the studies analyzed.

Pharmacogenomic testing is not yet part of routine clinical practice for methotrexate prescribing, so knowing about these variants is more useful as context than as something you can act on right now. The point is that if you feel terrible on a dose that your friend with the same condition handles easily, there is likely a biological explanation. You are not being dramatic, and the right response is to work with your doctor on adjustments rather than powering through.

When Fatigue Warrants a Treatment Change

For most people, the combination of folic acid, dose timing, and lifestyle adjustments brings methotrexate fatigue down to a tolerable level. But there is a threshold beyond which the tiredness undermines the point of the treatment. If you are sleeping through weekends to recover from your dose, missing work regularly, or finding that fatigue has shrunk your life in ways you are not willing to accept, those are signals that your treatment plan needs revision.

Options at that point include lowering the methotrexate dose if your disease is well controlled enough to allow it, switching from oral to subcutaneous delivery if you have not tried that yet, or transitioning to a different disease-modifying drug entirely. Biologic therapies, which target specific parts of the immune system rather than broadly interfering with folate metabolism, tend to have different side-effect profiles. In survey data, fatigue rates dropped substantially for patients on biologics without methotrexate compared to those on methotrexate alone.¹² That said, biologics come with their own risks and costs, and methotrexate remains part of many combination regimens precisely because it is so effective at controlling disease. The decision is always a trade-off, and fatigue severity is a legitimate factor in making it.